ENGYS is pleased to announce its participation in the ROMed2VR project, aimed at improving pre-surgical planning for congenital heart defects through the integration of Computational Fluid Dynamics (CFD) and Virtual Reality (VR) technologies. This initiative seeks to develop a streamlined computational procedure that leverages open-source CFD and Reduced Order Models (ROM) to enhance the precision and effectiveness of Modified Blalock-Taussig Shunt procedures.
The project kicked off with a meeting held in Trieste, Italy, on 25 November 2024, where key objectives and collaborative strategies were outlined. ENGYS will contribute its expertise in open-source CFD solutions to support the development of the ROMed2VR system.
The consortium partners include RBF Morph, specialists in Reduced Order Models for CFD applications; InSilicoTrials Technologies, developers of digital platforms for medical and pharmaceutical simulations; and the BioCardioLab of “Fondazione Toscana Gabriele Monasterio,” a research institution focusing on cardiovascular innovations. Together, these organisations bring a diverse range of expertise to ensure the project’s success.
Project Details:
- Acronym: ROMed2VR
- Title: Virtual Reality Empowered by Computational Fluid Dynamics Reduced Order Models to Support Pre-Surgery Medical Planning
- Duration: 12 months (1 November 2024 to 31 October 2025)
- Total Cost: €426,644.42
- Total Funding: €319,010.23
By integrating advanced CFD simulations with VR, the ROMed2VR project aims to provide medical professionals with enhanced tools for planning and executing surgical interventions, ultimately improving patient outcomes.
For more information, please contact:
Emiliano Costa, PhD
Programme Manager
[email protected]
engys.com